Sorry, you need to enable JavaScript to visit this website.
Skip to main content
 

Search

Joseph Erhardt, Ph.D.

Joseph Erhardt

JOSEPH ERHARDT, Ph.D.

VICE PRESIDENT
ONCOLOGY SCIENTIFIC PARTNERSHIP STRATEGY

Joseph Erhardt, Ph.D. is Vice President, Oncology Scientific Partnership Strategy at Janssen Research & Development, LLC. In this role, he is responsible for strategic oversight and implementation of scientific partnership strategies for the Disease Area Strongholds in collaboration with Johnson & Johnson Innovation centers in the United States and Europe.

Joseph joined Janssen in 2012, serving as the Compound Development Team Leader for one of Janssen’s investigational compounds prior to his current position. Before joining Janssen, Joseph was the Head of Portfolio Strategy and Operations for Drug Discovery and Early Development at GlaxoSmithKline. In that role, he led the creation and implementation of strategic business planning for the unit.

In addition to roles in portfolio strategy, Joseph has led global oncology development teams in both early and late phases, including projects that he championed through rapid development paths into early pivotal studies, resulting in several approvals. Earlier in his career, he led a small molecule drug discovery laboratory and multiple oncology programs from late lead optimization through Investigational New Drug (IND) submission and early development.

Joseph received his doctorate in Pharmacology from the University of Pennsylvania and conducted his post-doctoral research at SmithKline Beecham in the Department of Pharmacology.